COPD activates bitter taste receptors, the target of asthma treatment

Published Date: 17 Mar 2023

Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...

Read Full News

Latest News

Treprostinil Can Slow Lung Decline in Pulmonary Fibrosis

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with idiopathic pulmonary fibrosis.

Can Past Sleep Problems Hinder Smoking Cessation?

People with existing sleep problems may find it harder to quit smoking when seeking help to stop using tobacco.

Fan-to-Face Therapy May Ease Breathlessness in Lung Disease

Adding fan-to-face therapy to a supervised exercise training program lowers exertional breathlessness across training sessions and improves training tolerability in patients with chronic lung disease.

Preterm BPD May Reduce Exercise Capacity at School Age

School-aged children born prematurely with bronchopulmonary dysplasia may have exercise-related limitations compared with healthy term-born peers.

Gossamer Bio Shares Plummet as Lung Disease Drug Fails Late-stage Trial

Gossamer Bio's experimental treatment failed to significantly improve exercise capacity in patients with a rare ⁠lung condition in a late-stage study, knocking the drug...

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

Todays Updates

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

Previously treated patients with NSCLC respond to anti-CTLA-4 therapy.

Todays Updates

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

Previously treated patients with NSCLC respond to anti-CTLA-4 therapy.

Latest News

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with idiopathic pulmonary fibrosis.

People with existing sleep problems may find it harder to quit smoking when seeking help to stop using tobacco.

Adding fan-to-face therapy to a supervised exercise training program lowers exertional breathlessness across training sessions and improves training tolerability in patients with chronic lung disease.

School-aged children born prematurely with bronchopulmonary dysplasia may have exercise-related limitations compared with healthy term-born peers.

Gossamer Bio's experimental treatment failed to significantly improve exercise capacity in patients with a rare ⁠lung condition in a late-stage study, knocking the drug...

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

News All Time

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

5 Pulmonology Headlines You Missed in December 2025

5 Pulmonology Headlines You Missed in December 2025

Q4 2025 Recap: Pulmonology News and Updates

Q4 2025 Recap: Pulmonology News and Updates

Pulmonology in 2025: Year in Review

Pulmonology in 2025: Year in Review

Asthma in 2025: Year in Review

Asthma in 2025: Year in Review

COPD in 2025: Year in Review

COPD in 2025: Year in Review

Characterizing COPD - Lung Cancer Patients, with Joseph Friedberg, MD Joseph Friedberg, MD, Kevin Kunzmann

Friedberg discusses the inconsistent clinical pathways from disease progression to intervention in patients with a pair of highly deadly lung diseases.

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

Sleep Disorders Linked to Poorer Symptom Control in Severe Asthma

Sleep Disorders Linked to Poorer Symptom Control in Severe Asthma

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal

Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal

Recommended News For You

Inner Thoughts of Leonard Bernstein, the "Maestro".

GLP-1 Receptor antagonists used in a study allay fears about thyroid cancer.

An inadvertent loss of weight may be an indication to consult a physician, according to research.

investigating radiation oncology applications of artificial general intelligence.

Study identifies new approach to protect the brain during radiation therapy

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.

Recommended Articles For You

Understanding the Rare Disease: Werner Syndrome Explained  

Unlocking the Potential of Cancer Antigen 19-9 for Early Detection 

Cowden Syndrome and Cancer: Understanding the Risk Factors  

RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

2.

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

3.

Patients face high out-of-pocket costs after incident cancer diagnosis

4.

Childhood cancer survivors face new health problems later in life, study shows

5.

Mutation Clearance After Transplant Linked to Better Outcomes in Myelofibrosis

1.

The Statistical Horizon of Colorectal Cancer: From Global Trends to Precision Therapies and Colorectal Cancer 2025 Forecasts

2.

Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options 

3.

Understanding Histiocytosis: Symptoms, Causes, and Treatment Options

4.

Hepatocellular Carcinoma: Emerging Trends and Innovations in Diagnosis and Management

5.

Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

2.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

3.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

4.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

5.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot